We Love Fitness

breast cancer survival: femara better than tamoxifen

Older women with early breast cancers have fewer recurrences and significantly longer survival times when they take the aromatase inhibitor Femara (letrozole) instead of tamoxifen, a long-term follow-up study shows.


Home

 Articles & News
We Love Fitness - 2013